Journal of Renal Nutrition
Volume 21, Issue 2 , Pages 140-148 , March 2011

Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey

  • Orlando M. Gutiérrez, MD, MMSc

      Affiliations

    • Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
    • Corresponding Author InformationAddress reprint requests to Orlando M. Gutiérrez, MD, MMSc, Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th Street, CRB C-221, Room 815, Miami, FL 33136.
    • ,
  • Tamara Isakova, MD, MMSc

      Affiliations

    • Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Gwen Enfield, RD, CDE

      Affiliations

    • Clinical Research Center, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Myles Wolf, MD, MMSc

      Affiliations

    • Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida

References 

  1. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879–885
  2. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520–528
  3. Schwarz S, Trivedi B, Kalanter-Zadeh K, et al. Association of disorders of mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol. 2006;1:825–831
  4. Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627–2633
  5. Foley RN, Collins AJ, Herzog CA, et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397–404
  6. Mathew S, Tustison KS, Sugatani T, et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol. 2008;19:1092–1105
  7. Amann K, Tornig J, Kugel B, et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int. 2003;63:1296–1301
  8. Ibels LS, Alfrey AC, Haut L, et al. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med. 1978;298:122–126
  9. Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4:1370–1373
  10. Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54:18–23
  11. Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301:629–635
  12. Calvo MS. Dietary considerations to prevent loss of bone and renal function. Nutrition. 2000;16:564–566
  13. Bell RR, Draper HH, Tzeng DY, et al. Physiological responses of human adults to foods containing phosphate additives. J Nutr. 1977;107:42–50
  14. Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20:1504–1512
  15. Baker EA, Schootman M, Barnidge E, et al. The role of race and poverty in access to foods that enable individuals to adhere to dietary guidelines. Prev Chronic Dis. 2006;3:A76
  16. Block JP, Scribner RA, DeSalvo KB. Fast food, race/ethnicity, and income: a geographic analysis. Am J Prev Med. 2004;27:211–217
  17. Powell LM, Chaloupka FJ, Bao Y. The availability of fast-food and full-service restaurants in the United States: associations with neighborhood characteristics. Am J Prev Med. 2007;33:S240–S245
  18. Butt S, Leon JB, David CL, et al. The prevalence and nutritional implications of fast food consumption among patients receiving hemodialysis. J Ren Nutr. 2007;17:264–268
  19. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17:350–354
  20. de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2009;53:399–407
  21. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?. Semin Dial. 2003;16:186–188
  22. National Center for Health Statistics: Plan and operation of the Third National and Nutrition Examination Survey 1988-1994. National Center for Health Statistics. Vital Health Stat 1; 1994;
  23. Martins D, Tareen N, Zadshir A, et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006;47:965–971
  24. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50:918–926
  25. Hu FB, Rimm E, Smith-Warner SA, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr. 1999;69:243–249
  26. Karvetti RL, Knuts LR. Validity of the 24-hour dietary recall. J Am Diet Assoc. 1985;85:1437–1442
  27. Kennedy ET, Ohls J, Carlson S, et al. The Healthy Eating Index: design and applications. J Am Diet Assoc. 1995;95:1103–1108
  28. Foley RN, Wang C, Ishani A, et al. NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol. 2007;18:2575–2582
  29. Briefel RR, Sempos CT, McDowell MA, et al. Dietary methods research in the third National Health and Nutrition Examination Survey: underreporting of energy intake. Am J Clin Nutr. 1997;65:S1203–S1209
  30. Robbins JM, Vaccarino V, Zhang H, et al. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91:76–83
  31. Tanaka H, Hamano T, Fujii N, et al. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009;45:949–955
  32. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007;20:295–301
  33. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161:1207–1216
  34. Hossain MP, Goyder EC, Rigby JE, et al. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166–174
  35. Karalis M. Food and Drug Administration petition on food labeling: an update from the American Dietetic Association and National Kidney Foundation. J Ren Nutr. 2007;17:423–424
  36. Sehgal AR, Sullivan C, Leon JB, et al. Public health approach to addressing hyperphosphatemia among dialysis patients. J Ren Nutr. 2008;18:256–261
  37. Oenning LL, Vogel J, Calvo MS. Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc. 1988;88:1076–1080
  38. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91:3144–3149
  39. Burnett SM, Gunawardene SC, Bringhurst FR, et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21:1187–1196
  40. Calvo MS, Kumar R, Heath H. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab. 1990;70:1334–1340
  41. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  42. Gutierrez O, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among hemodialysis patients. N Engl J Med. 2008;359:584–592

 This study was supported by the American Kidney Fund Clinical Scientist in Nephrology Fellowship (to Dr. Isakova) and grants K23DK081673 (to Dr. Gutiérrez), R01DK076116 and R01DK081374 (to Dr. Wolf) from the National Institutes of Health.

 Dr. Gutiérrez reports accepting speaking honoraria from Abbott. Dr. Isakova reports receiving honoraria from Shire. Dr. Wolf reports receiving research support from Shire and honoraria from Abbott, Genzyme, Shire, and Davita.

PII: S1051-2276(10)00072-5

doi: 10.1053/j.jrn.2010.03.001

Journal of Renal Nutrition
Volume 21, Issue 2 , Pages 140-148 , March 2011

Article Tools

* Image Usage & Resolution